All In MedTech

Device Trial Radar · NCT06052371

Project VerioVue Enhancements - Neonate Study

VerioVue Enhancements Regulatory Clinical Evaluation - Professional Comparison to Validated Method: Neonate Study

Last checked: Nov 20, 2026Latest source record: Dec 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

99

Actual

Start

Oct 16, 2023

Primary completion

Dec 1, 2023

Study completion Dec 1, 2023

Sponsor

Lead sponsor
LifeScan Scotland LtdNot on our public-company list
Sponsor type
Industry
First posted
Sep 25, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 0 days, up to 28 days
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this performance evaluation is to compare the blood glucose results obtained using the VerioVue Blood Glucose Monitoring system (BGMS) with those obtained from a validated comparator method (iSTAT 1 Analyser) using blood obtained from neonates. The main question it aims to answer is: •How accurate is the VerioVue BGMS when compared to a product that has already been confirmed as accurate (iSTAT 1 Analyser) when hospital staff test blood taken from neonates on these instruments? Participants (neonates) will have a small amount of blood taken from a heel prick (performed by a HCP for medical purposes) or from an existing arterial line.

Conditions

  • Diabetes Mellitus

Interventions

  • VerioVue (Enhancements) blood glucose monitoring systemDevice

    VerioVue meter with expanded haematocrit range

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Performance evaluation: blood glucose monitoring system accuracy: BGMS vs reference instrumentTime frame: 1 hour

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Whipps Cross University Hospital (Barts Health NHS Trust)

    London, United Kingdom

  • Queens Hospital Romford (BHRUT)

    London, United Kingdom

  • The Royal Oldham Hospital (Northern Care Alliance NHS Foundation Trust)

    Manchester, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.